MAPT and Alzheimer disease: Apart from being a substrate for the development of prion diseases, PrPC can serve as a receptor for cytotoxic amyloid-β (Aβ) oligomers [20,28] and toxic soluble aggregates of tau protein in AD and other tauopathies [29,30].